Animal models for perinatal transmission of HIV-1

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 3, 2006, Pages 2828-2844

  Jayaraman, Pushpa ^a   Haigwood, Nancy L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

AIDS; Animal models; Cats; Feline; FIV; HIV 1; Mice; MIV; Mother to child transmission; Murine; Neonates; Nonhuman primates; Pediatric pathogenesis; Review; SHIV; SIV; Therapies; Vaccines

Indexed keywords

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33744459252     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2012     Document Type: Review

References (150)

1. UNAIDS/WHO: AIDS Epidemic Update 2004. Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization, 1-94 (2004).
2. Thorne, C. & M. L. Newell: Mother-to-child transmission of HIV infection and its prevention. Curr HIV Res 1, 447-62 (2003)
3. Rousseau, C. M., R. W. Nduati, B. A. Richardson, G. C. John-Stewart, D. A. Mbori-Ngacha, J. K. Kreiss & J. Overbaugh: Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis 190, 1880-8 (2004)
4. Ruprecht, R. M., F. Ferrantelli, M. Kitabwalla, W. Xu & H. M. McClure: Antibody protection: passive immunization of neonates against oral AIDS virus challenge. Vaccine 21, 3370-3 (2003)
5. Rousseau, C. M., R. W. Nduati, B. A. Richardson, M. S. Steele, G. C. John-Stewart, D. A. Mbori-Ngacha, J. K. Kreiss & J. Overbaugh: Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 187, 741-7 (2003)
6. Richardson, B. A., G. C. John-Stewart, J. P. Hughes, R. Nduati, D. Mbori-Ngacha, J. Overbaugh & J. K. Kreiss: Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers. J Infect Dis 187, 736-40 (2003)
7. Nduati, R., G. John, D. Mbori-Ngacha, B. Richardson, J. Overbaugh, A. Mwatha, J. Ndinya-Achola, J. Bwayo, F. E. Onyango, J. Hughes & J. Kreiss: Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. Jama 283, 1167-74 (2000)
8. Lewis, P., R. Nduati, J. K. Kreiss, G. C. John, B. A. Richardson, D. Mbori-Ngacha, J. Ndinya-Achola & J. Overbaugh: Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis 177, 34-9 (1998)
9. Nduati, R. W., G. C. John, B. A. Richardson, J. Overbaugh, M. Welch, J. Ndinya-Achola, S. Moses, K. Holmes, F. Onyango & J. K. Kreiss: Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis 172, 1461-8 (1995)
10. Mock, P. A., N. Shaffer, C. Bhadrakom, W. Siriwasin, T. Chotpitayasunondh, S. Chearskul, N. L. Young, A. Roongpisuthipong, P. Chinayon, M. L. Kalish, B. Parekh & T. D. Mastro: Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. Aids 13, 407-14 (1999)
11. Fang, G., H. Burger, R. Crimson, P. Tropper, S. Nachman, D. Mayers, O. Weislow, R. Moore, C. Reyelt, N. Hutcheon, D. Baker & B. Weiser: Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 92, 12100-4 (1995)
12. Weiser, B., S. Nachman, P. Tropper, K. H. Viscosi, R. Grimson, G. Baxter, G. Fang, C. Reyelt, N. Hutcheon & H. Burger: Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA 91, 8037-41 (1994)
13. Bulterys, M., S. Landesman, D. N. Burns, A. Rubinstein & J. J. Goedert: Sexual behavior and injection drug use during pregnancy and vertical transmission of HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 15, 76-82 (1997)
14. MacDonald, K. S., J. Embree, S. Njenga, N. J. Nagelkerke, I. Ngatia, Z. Mohammed, B. H. Barber, J. Ndinya-Achola, J. Bwayo & F. A. Plummer: Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 177, 551-6 (1998)
15. Kuhn, L., D. Trabattoni, C. Kankasa, K. Semrau, P. Kasonde, F. Lissoni, M. Sinkala, M. Ghosh, C. Vwalika, G. M. Aldrovandi, D. M. Thea & M. Clerici: Alpha-defensins in the prevention of HIV transmission among breastfed infants. J Acquir Immune Defic Syndr 39, 138-42 (2005)
16. Taha, T. E., N. I. Kumwenda, D. R. Hoover, S. A. Fiscus, G. Kafulafula, C. Nkhoma, S. Nour, S. Chen, G. Liomba, P. G. Miotti & R. L. Broadhead: Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. Jama 292, 202-9 (2004)
17. Taha, T. E., N. I. Kumwenda, A. Gibbons, R. L. Broadhead, S. Fiscus, V. Lema, G. Liomba, C. Nkhoma, P. G. Miotti & D. R. Hoover: Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet 362, 1171-7 (2003)
18. Shaffer, N., R. Chuachoowong, P. A. Mock, C. Bhadrakom, W. Siriwasin, N. L. Young, T. Chotpitayasunondh, S. Chearskul, A. Roongpisuthipong, P. Chinayon, J. Karon, T. D. Mastro & R. J. Simonds: Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 353, 773-80 (1999)
19. Cao, Y., P. Krogstad, B. T. Korber, R. A. Koup, M. Muldoon, C. Macken, J. L. Song, Z. Jin, J. Q. Zhao, S. Clapp, I. S. Chen, D. D. Ho & A. J. Ammann: Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 3, 549-52 (1997)
20. Sperling, R. S., D. E. Shapiro, R. W. Coombs, J. A. Todd, S. A. Herman, G. D. McSherry, M. J. O'Sullivan, R. B. Van Dyke, E. Jimenez, C. Rouzioux, P. M. Flynn & J. L. Sullivan: Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 315, 1621-9 (1996)
21. John, G. C., R. W. Nduati, D. A. Mbori-Ngacha, B. A. Richardson, D. Panteleeff, A. Mwatha, J. Overbaugh, J. Bwayo, J. O. Ndinya-Achola & J. K. Kreiss: Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 183, 206-212 (2001)
22. John, G. C., R. W. Nduati, D. Mbori-Ngacha, J. Overbaugh, M. Welch, B. A. Richardson, J. Ndinya-Achola, J. Bwayo, J. Krieger, F. Onyango & J. K. Kreiss: Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 175, 57-62 (1997)
23. Benki, S., S. B. Mostad, B. A. Richardson, K. Mandaliya, J. K. Kreiss & J. Overbaugh: Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycle. J Infect Dis 189, 2192-201 (2004)
24. Reichelderfer, P. S., R. W. Coombs, D. J. Wright, J. Cohn, D. N. Burns, S. Cu-Uvin, P. A. Baron, M. H. Coheng, A. L. Landay, S. K. Beckner, S. R. Lewis & A. A. Kovacs: Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. Aids 14, 2101-7 (2000)
25. Dickover, R. E., E. M. Garratty, S. Plaeger & Y. J. Bryson: Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol 75, 2194-203 (2001)
26. Wolinsky, S. M., C. M. Wike, B. T. Korber, C. Hutto, W. P. Parks, L. L. Rosenblum, K. J. Kunstman, M. R. Furtado & J. L. Munoz: Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255, 1134-7 (1992)
27. Dealtry, G. B., M. K. O'Farrell & N. Fernandez: The Th2 cytokine environment of the placenta. Int Arch Allergy Immunol 123, 107-19 (2000)
28. Lim, K. J., O. A. Odukoya, R. A. Ajjan, T. C. Li, A. P. Weetman & I. D. Cooke: Profile of cytokine mRNA expression in peri-implantation human endometrium. Mol Hum Reprod 4, 77-81 (1998)
29. Lim, K. J., O. A. Odukoya, R. A. Ajjan, T. C. Li, A. P. Weetman & I. D. Cooke: The role of T-helper cytokines in human reproduction. Fertil Steril 73, 136-42 (2000)
30. Wilson, C. C., R. C. Brown, B. T. Korber, B. M. Wilkes, D. J. Ruhl, D. Sakamoto, K. Kunstman, K. Luzuriaga, I. C. Hanson, S. M. Widmayer, A. Wiznia, S. Clapp, A. J. Ammann, R. A. Koup, S. M. Wolinsky & B. D. Walker: Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant. J Virol 73, 3975-85 (1999)
31. Lathey, J. L., J. Tsou, K. Brinker, K. Hsia, W. A. Meyer, 3rd & S. A. Spector: Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission. J Infect Dis 180, 344-50 (1999)
32. Scarlatti, G., T. Leitner, V. Hodara, E. Halapi, P. Rossi, J. Albert & E. M. Fenyo: Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1. Aids 7 Suppl 2, S45-8 (1993)
33. Parren, P. W., M. Wang, A. Trkola, J. M. Binley, M. Purtscher, H. Katinger, J. P. Moore & D. R. Burton: Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1. J Virol 72, 10270-4 (1998)
34. Wu, X., A. B. Parast, B. A. Richardson, R. Nduati, G. John-Stewart, D. Mbori-Ngacha, S. M. J. Rainwater & J. Overbaugh: Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant. J. Virol. 80, 835-844 (2006)
35. Borkowsky, W., D. Wara, T. Fenton, J. McNamara, M. Kang, L. Mofenson, E. McFarland, C. Cunningham, A. M. Duliege, D. Francis, Y. Bryson, S. Burchett, S. A. Spector, L. M. Frenkel, S. Starr, R. Van Dyke & E. Jimenez: Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators. J Infect Dis 181, 890-6 (2000)
36. McFarland, E. J., W. Borkowsky, T. Fenton, D. Wara, J. McNamara, P. Samson, M. Kang, L. Mofenson, C. Cunningham, A. M. Duliege, F. Sinangil, S. A. Spector, E. Jimenez, Y. Bryson, S. Burchett, L. M. Frenkel, R. Yogev, F. Gigliotti, K. Luzuriaga & R. A. Livingston: Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp 120 vaccine. J Infect Dis 184, 1331-5 (2001)
37. Adkins, B., C. Leclerc & S. Marshall-Clarke: Neonatal adaptive immunity comes of age. Nat Rev Immunol 4, 553-64 (2004)
38. Lambert, P. H., M. Liu & C. A. Siegrist: Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med 11, S54-62 (2005)
39. Levy, J. A., A. D. Hoffman, S. M. Kramer, J. A. Landis, J. M. Shimabukuro & L. S. Oshiro: Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225, 840-2 (1984)
40. Luciw, P. A., S. J. Potter, K. Steimer, D. Dina & J. A. Levy: Molecular cloning of AIDS-associated retrovirus. Nature 312, 760-3 (1984)
41. Gallo, R. C., S. Z. Salahuddin, M. Popovic, G. M. Shearer, M. Kaplan, B. F. Haynes, T. J. Palker, R. Redfield, J. Oleske, B. Safai & et al.: Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-3 (1984)
42. Popovic, M., M. G. Sarngadharan, E. Read & R. C. Gallo: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497-500 (1984)
43. Schupbach, J., M. Popovic, R. V. Gilden, M. A. Gonda, M. G. Sarngadharan & R. C. Gallo: Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science 224, 503-5 (1984)
44. Shaw, G. M., B. H. Hahn, S. K. Arya, J. E. Groopman, R. C. Gallo & F. Wong-Staal: Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science 226, 1165-71 (1984)
45. Brun-Vezinet, F., C. Rouzioux, F. Barre-Sinoussi, D. Klatzmann, A. G. Saimot, W. Rozenbaum, D. Christol, J. C. Gluckmann, L. Montagnier & J. C. Chermann: Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet 1, 1253-6 (1984)
46. Brun-Vezinet, F., C. Rouzioux, L. Montagnier, S. Chamaret, J. Gruest, F. Barre-Sinoussi, D. Geroldi, J. C. Chermann, J. McCormick, S. Mitchell & et al.: Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science 226, 453-6 (1984)
47. Montagnier, L., J. C. Chermann, F. Barre-Sinoussi, D. Klatzmann, S. Wain-Hobson, M. Alizon, F. Clavel, F. Brun-Vezinet, E. Vilmer, C. Rouzioux & et al.: Lymphadenopathy associated virus and its etiological role in AIDS. Princess Takamatsu Symp 15, 319-31 (1984)
48. Coffin, J., A. Haase, J. A. Levy, L. Montagnier, S. Oroszlan, N. Teich, H. Temin, K. Toyoshima, H. Varmus, P. Vogt & et al.: Human immunodeficiency viruses. Science 232, 697 (1986)
49. Coffin, J., A. Haase, J. A. Levy, L. Montagnier, S. Oroszlan, N. Teich, H. Temin, K. Toyoshima, H. Varmus, P. Vogt & et al.: What to call the AIDS virus? Nature 321, 10 (1986)
50. Kulaga, H., T. Folks, R. Rutledge, M. E. Truckenmiller, E. Gugel & T. J. Kindt: Infection of rabbits with human immunodeficiency virus 1. A small animal model for acquired immunodeficiency syndrome. J Exp Med 169, 321-6 (1989)
51. Simpson, R. M., B. S. Hubbard, D. W. Alling, R. Teller, M. A. Fain, F. S. Bowers & T. J. Kindt: Rabbits transfused with human immunodeficiency virus type 1-infected blood develop immune deficiency with CD4+ lymphocytopenia in the absence of clear evidence for HIV type 1 infection. AIDS Res Hum Retroviruses 11, 297-306 (1995)
52. Varnier, O. E. & T. J. Kindt: Current status of HIV-1 infection in the rabbit. AIDS Res Hum Retroviruses 8, 533-5 (1992)
53. Gardner, M. B. & P. A. Luciw: Animal models of AIDS. Faseb J 3, 2593-606 (1989)
54. Yap, M. W., S. Nisole, C. Lynch & J. P. Stoye: Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci USA 101, 10786-91 (2004)
55. Hofmann, W., D. Schubert, J. LaBonte, L. Munson, S. Gibson, J. Scammell, P. Ferrigno & J. Sodroski: Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol 73, 10020-8 (1999)
56. Hatziioannou, T., S. Cowan, U. K. Von Schwedler, W. I. Sundquist & P. D. Bieniasz: Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J Virol 78, 6005-12 (2004)
57. Towers, G. J., T. Hatziioannou, S. Cowan, S. P. Goff, J. Luban & P. D. Bieniasz: Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med 9, 1138-43 (2003)
58. Haigwood, N. L.: Predictive value of primate models for AIDS. AIDS Rev 6, 187-98 (2004)
59. Hirsch, V. M., R. A. Olmsted, M. Murphey-Corb, R. H. Purcell & P. R. Johnson: An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 339, 389-92 (1989)
60. Hirsch, V. M. & P. R. Johnson: Pathogenic diversity of simian immunodeficiency viruses. Virus Res 32, 183-203 (1994)
61. Gao, F., E. Bailes, D. L. Robertson, Y. Chen, C. M. Rodenburg, S. F. Michael, L. B. Cummins, L. O. Arthur, M. Peeters, G. M. Shaw, P. M. Sharp & B. H. Hahn: Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397, 436-41 (1999)
62. Korber, B., M. Muldoon, J. Theiler, F. Gao, R. Gupta, A. Lapedes, B. H. Hahn, S. Wolinsky & T. Bhattacharya: Timing the ancestor of the HIV-1 pandemic strains. Science 288, 1789-96 (2000)
63. Santiago, M. L., C. M. Rodenburg, S. Kamenya, F. Bibollet-Ruche, F. Gao, E. Bailes, S. Meleth, S. J. Soong, J. M. Kilby, Z. Moldoveanu, B. Fahey, M. N. Muller, A. Ayouba, E. Nerrienet, H. M. McClure, J. L. Heeney, A. E. Pusey, D. A. Collins, C. Boesch, R. W. Wrangham, J. Goodall, P. M. Sharp, G. M. Shaw & B. H. Hahn: SIVcpz in wild chimpanzees. Science 295, 465 (2002)
64. Shibata, R., F. Maldarelli, C. Siemon, T. Matano, M. Parta, G. Miller, T. Fredrickson & M. A. Martin: Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing. J Infect Dis 176, 362-73 (1997)
65. Chen, J., E. Ido, M. Jin, T. Kuwata, T. Igarashi, A. Mizuno, Y. Koyanagi & M. Hayami: Replication of human immunodeficiency virus type 1 (HIV-1), simian immunodeficiency virus strain mac (SIVmac) and chimeric HIV-1/SIVmac viruses having env genes derived from macrophage-tropic viruses: an indication of different mechanisms of macrophage-tropism in human and monkey cells. J Gen Virol 79 (Pt 4), 741-5 (1998)
66. Bogers, W. M., R. Dubbes, P. ten Haaft, H. Niphuis, C. Cheng-Mayer, C. Stahl-Hennig, G. Hunsmann, T. Kuwata, M. Hayami, S. Jones, S. Ranjbar, N. Almond, J. Stott, B. Rosenwirth & J. L. Heeney: Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta. Virology 236, 110-7 (1997)
67. Browning, J., J. W. Horner, M. Pettoello-Mantovani, C. Raker, S. Yurasov, R. A. DePinho & H. Goldstein: Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc Natl Acad Sci U S A 94, 14637-41 (1997)
68. Sawada, S., K. Gowrishankar, R. Kitamura, M. Suzuki, G. Suzuki, S. Tahara & A. Koito: Disturbed CD4+ T cell homeostasis and in vitro HIV-I susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors. J Exp Med 187, 1439-49 (1998)
69. Keppler, O. T., F. J. Welte, T. A. Ngo, P. S. Chin, K. S. Patton, C. L. Tsou, N. W. Abbey, M. E. Sharkey, R. M. Grant, Y. You, J. D. Scarborough, W. Ellmeier, D. R. Littman, M. Stevenson, I. F. Charo, B. G. Herndier, R. F. Speck & M. A. Goldsmith: Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J Exp Med 195, 719-36 (2002)
70. Keppler, O. T., W. Yonemoto, F. J. Welte, K. S. Patton, D. Iacovides, R. E. Atchison, T. Ngo, D. L. Hirschberg, R. F. Speck & M. A. Goldsmith: Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J Virol 75, 8063-73 (2001)
71. McCune, J., H. Kaneshima, J. Krowka, R. Namikawa, H. Outzen, B. Peault, L. Rabin, C. C. Shih, E. Yee, M. Lieberman & et al.: The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu Rev Immunol 9, 399-429 (1991)
72. McCune, J. M.: Development and applications of the SCID-hu mouse model. Semin Immunol 8, 187-96 (1996)
73. Aldrovandi, G. M., G. Feuer, L. Gao, B. Jamieson, M. Kristeva, I. S. Chen & J. A. Zack: The SCID-hu mouse as a model for HIV-1 infection. Nature 363, 732-6 (1993)
74. Jamieson, B. D., G. M. Aldrovandi & J. A. Zack: The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS. Semin Immunol 8, 215-21 (1996)
75. Duggan, J., H. Okonta & J. Chakraborty: Vertical transmission of a murine retro virus, ts1. Viral Immunol 17, 266-78 (2004)
76. Chakraborty, J., S. Clark, H. Okonta & J. Duggan: A small animal model for mother-to-fetus transmission of ts1, a murine retrovirus. Viral Immunol 16, 191-201 (2003)
77. Bonyhadi, M. L., L. Rabin, S. Salimi, D. A. Brown, J. Kosek, J. M. McCune & H. Kaneshima: HIV induces thymus depletion in vivo. Nature 363, 728-32 (1993)
78. Jenkins, M., M. B. Hanley, M. B. Moreno, E. Wieder & J. M. McCune: Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo. Blood 91, 2672-8 (1998)
79. Jamieson, B. D., C. H. Uittenbogaart, I. Schmid & J. A. Zack: High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. J Virol 71, 8245-53 (1997)
80. Coats, K. S.: The feline immunodeficiency virus-infected cat: a model for lentivirus-induced placental immunopathology and reproductive failure (mini-review). Am J Reprod Immunol 54, 169-85 (2005)
81. Bendinelli, M., M. Pistello, S. Lombardi, A. Poli, C. Garzelli, D. Matteucci, L. Ceccherini-Nelli, G. Malvaldi & F. Tozzini: Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev 8, 87-112 (1995)
82. Burkhard, M. J. & G. A. Dean: Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr HIV Res 1, 15-29 (2003)
83. Ticconi, C., M. Mapfumo, M. Dorrucci, N. Naha, E. Tarira, A. Pietropolli & G. Rezza: Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J Acquir Immune Defic Syndr 34, 289-94 (2003)
84. Shearer, W. T., C. Langston, D. E. Lewis, E. L. Pham, H. H. Hammill, C. A. Kozinetz, M. W. Kline, I. C. Hanson & E. J. Popek: Early spontaneous abortions and fetal thymic abnormalities in maternal-to-fetal HIV infection. Acta Paediatr Suppl 421, 60-4 (1997)
85. Weaver, C. C., S. C. Burgess, P. D. Nelson, M. Wilkinson, P. L. Ryan, C. A. Nail, K. A. Kelly-Quagliana, M. L. May, R. K. Reeves, C. R. Boyle & K. S. Coats: Placental immunopathology and pregnancy failure in the FIV-infected cat. Placenta 26, 138-47 (2005)
86. Rogers, A. B. & E. A. Hoover: Maternal-fetal feline immunodeficiency virus transmission: timing and tissue tropisms. J Infect Dis 178, 960-7 (1998)
87. Rogers, A. B. & E. A. Hoover: Fetal feline immunodeficiency virus is prevalent and occult. J Infect Dis 186, 895-904 (2002)
88. O'Neil, L. L., M. J. Burkhard & E. A. Hoover: Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J Virol 70, 2894-901 (1996)
89. Sellon, R. K., H. L. Jordan, S. Kennedy-Stoskopf, M. B. Tompkins & W. A. Tompkins: Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. J Virol 68, 3380-5 (1994)
90. Nevrard, C. H. F., M. Gaunt & C. D. Ockleford: Chapter 17. The Transfer of Passive and Active Immunity. In: The Immunology of the Fetus. Ed: G. Chaout. CRC Press, Inc., Boca Raton, FL (1990)
91. Ramsey, E. M.: The Placenta: Human and Animal. Prager Publishers, New York, NY (1982)
92. Tizard, I.: Veterinary Immunology, An Introduction. W. B. Saunders Company, Philadelphia, PA (1992)
93. Davison-Fairburn, B., J. Blanchard, F. S. Hu, L. Martin, R. Harrison, M. Ratterree & M. Murphey-Corb: Experimental infection of timed-pregnant rhesus monkeys with simian immunodeficiency virus (SIV) during early, middle, and late gestation. J Med Primatol 19, 381-93 (1990)
94. McClure, H. M., D. C. Anderson, A. A. Ansari & S. A. Klumpp: The simian immunodeficiency virus infected macaque: a model for pediatric AIDS. Pathol Biol (Paris) 40, 694-700 (1992)
95. McClure, H. M., D. C. Anderson, P. N. Fultz, A. A. Ansari, T. Jehuda-Cohen, F. Villinger, S. A. Klumpp, W. Switzer, E. Lockwood, A. Brodie & et al.: Maternal transmission of SIVsmm in rhesus macaques. J Med Primatol 20, 182-7 (1991)
96. Amedee, A. M., N. Lacour & M. Ratterree: Mother-to-infant transmission of SIV via breast-feeding in rhesus macaques. J Med Primatol 32, 187-93 (2003)
97. Ho, R. J., K. Larsen, L. Kinman, C. Sherbert, X. Y. Wang, E. Finn, C. Nosbisch, A. Schmidt, D. Anderson, S. L. Hu, M. Agy, H. Ochs, W. R. Morton & J. D. Unadkat: Characterization of a maternal-fetal HIV transmission model using pregnant macaques infected with HIV-2(287). J Med Primatol 30, 131-40 (2001)
98. Ho, R. J., M. B. Agy, W. R. Morton, M. Scheibel, J. McClure, A. Watson, S. L. Hu, C. Nosbisch, N. Dorofeeva & J. D. Unadkat: Development of a chronically catheterized maternal-fetal macaque model to study in utero mother-to-fetus HIV transmission: a preliminary report. J Med Primatol 25, 218-24 (1996)
99. Amedee, A. M., J. Rychert, N. Lacour, L. Fresh & M. Ratterree: Viral and immunological factors associated with breast milk transmission of SIV in rhesus macaques. Retrovirology 1, 17 (2004)
100. Rychert, J. & A. M. Amedee: The antibody response to SIV in lactating rhesus macaques. J Acquir Immune Defic Syndr 38, 135-41 (2005)
101. Jayaraman, P., D. Mohan, P. Polacino, L. Kuller, N. Sheikh, H. Bielefeldt-Ohmann, B. Richardson, D. Anderson, S. L. Hu & N. L. Haigwood: Perinatal transmission of SHIV-SF162P3 in Macaca nemestrina. J Med Primatol 33, 243-50 (2004)
102. Herz, A. M., M. N. Robertson, J. B. Lynch, A. Schmidt, M. Rabin, C. Sherbert, M. B. Agy, D. Anderson, S. L. Hu, P. D. Greenberg & W. R. Morton: Viral dynamics of early HIV infection in neonatal macaques after oral exposure to HIV-2287: an animal model with implications for maternal-neonatal HIV transmission. J Med Primatol 31, 29-39 (2002)
103. Van Rompay, K. K., C. J. Berardi, S. Dillard-Telm, R. P. Tarara, D. R. Canfield, C. R. Valverde, D. C. Montefiori, K. S. Cole, R. C. Montelaro, C. J. Miller & M. L. Marthas: Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis 177, 1247-59 (1998)
104. Baba, T. W., J. Koch, E. S. Mittler, M. Greene, M. Wyand, D. Penninck & R. M. Ruprecht: Mucosal infection of neonatal rhesus monkeys with cell-free SIV. AIDS Res Hum Retroviruses 10, 351-7 (1994)
105. Ruprecht, R. M., T. W. Baba, V. Liska, N. B. Ray, L. N. Martin, M. Murphey-Corb, T. A. Rizvi, B. J. Bernacky, M. E. Keeling, H. M. McClure & J. Andersen: Oral transmission of primate lentiviruses. J Infect Dis 179 Suppl 3, S408-12 (1999)
106. Van Rompay, K. K., K. Abel, J. R. Lawson, R. P. Singh, K. A. Schmidt, T. Evans, P. Earl, D. Harvey, G. Franchini, J. Tartaglia, D. Montefiori, S. Hattangadi, B. Moss & M. L. Marthas: Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. J Acquir Immune Defic Syndr 38, 124-34 (2005)
107. Baba, T. W., Y. S. Jeong, D. Pennick, R. Bronson, M. F. Greene & R. M. Ruprecht: Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-5 (1995)
108. Amedee, A. M., N. Lacour, J. L. Gierman, L. N. Martin, J. E. Clements, R. Bohm, Jr., R. M. Harrison & M. Murphey-Corb: Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol 69, 7982-90 (1995)
109. Jaspan, H. B., J. E. Robinson, A. M. Amedee, R. B. Van Dyke & R. F. Garry: Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies. J Clin Virol 31, 190-7 (2004)
110. Scott, G. B., C. Hutto, R. W. Makuch, M. T. Mastrucci, T. O'Connor, C. D. Mitchell, E. J. Trapido & W. P. Parks: Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 321, 1791-6 (1989)
111. Veazey, R. S., J. D. Lifson, I. Pandrea, J. Purcell, M. Piatak, Jr. & A. A. Lackner: Simian immunodeficiency virus infection in neonatal macaques. J Virol 77, 8783-92 (2003)
112. Veazey, R. S., M. DeMaria, L. V. Chalifoux, D. E. Shvetz, D. R. Pauley, H. L. Knight, M. Rosenzweig, R. P. Johnson, R. C. Desrosiers & A. A. Lackner: Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280, 427-31 (1998)
113. Harouse, J. M., A. Gettie, R. C. H. Tan, J. Blanchard & C. Cheng-Mayer: Distinct Pathogenic Sequela in Rhesus Macaques Infected with CCR5 or CXCR4 Utilizing SHIVs. Science 284, 816-819 (1999)
114. Chase, A., Y. Zhou & R. F. Siliciano: HIV-1-induced depletion of CD4(+) T cells in the gut: mechanism and therapeutic implications. Trends Pharmacol Sci 27, 4-7 (2006)
115. Haase, A. T.: Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 5, 783-92 (2005)
116. Li, Q., L. Duan, J. D. Estes, Z. M. Ma, T. Rourke, Y. Wang, C. Reilly, J. Carlis, C. J. Miller & A. T. Haase: Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434, 1148-52 (2005)
117. Brenchley, J. M., T. W. Schacker, L. E. Ruff, D. A. Price, J. H. Taylor, G. J. Beilman, P. L. Nguyen, A. Khoruts, M. Larson, A. T. Haase & D. C. Douek: CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract. J. Exp. Med. 200, 749-759 (2004)
118. Lane, J. H., A. F. Tarantal, D. Pauley, M. Marthas, C. J. Miller & A. A. Lackner: Localization of simian immunodeficiency virus nucleic acid and antigen in brains of fetal macaques inoculated in utero. Am J Pathol 149, 1097-104 (1996)
119. Tsai, C. C., K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischofberger, R. E. Benveniste & R. Black: Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 270, 1197-9 (1995)
120. Van Rompay, K. K., J. M. Cherrington, M. L. Marthas, C. J. Berardi, A. S. Mulato, A. Spinner, R. P. Tarara, D. R. Canfield, S. Telm, N. Bischofberger & N. C. Pedersen: 9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. Antimicrob Agents Chemother 40, 2586-91 (1996)
121. Ho, R. J., K. Larsen, T. Bui, X. Y. Wang, A. M. Herz, C. Sherbert, E. Finn, C. Nosbisch, A. Schmidt, D. Anderson, M. Agy, W. R. Morton & J. D. Unadkat: Suppression of maternal virus load with zidovudine, didanosine, and indinavir combination therapy prevents mother-to-fetus HIV transmission in macaques. J Acquir Immune Defic Syndr 25, 140-9 (2000)
122. Van Rompay, K. K., R. P. Singh, L. L. Brignolo, J. R. Lawson, K. A. Schmidt, B. Pahar, D. R. Canfield, R. P. Tarara, D. L. Sodora, N. Bischofberger & M. L. Marthas: The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters. J Acquir Immune Defic Syndr 36, 900-14 (2004)
123. Forthal, D. N., G. Landucci & E. S. Daar: Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J Virol 75, 6953-61 (2001)
124. Forthal, D. N., G. Landucci, R. Haubrich, B. Keenan, B. D. Kuppermann, J. G. Tilles & J. Kaplan: Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients. J Infect Dis 180, 1338-41 (1999)
125. Forthal, D. N., G. Landucci & B. Keenan: Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD44-lymphocyte count. AIDS Res Hum Retroviruses 17, 553-61 (2001)
126. Ferrantelli, F., R. A. Rasmussen, K. A. Buckley, P. L. Li, T. Wang, D. C. Montefiori, H. Katinger, G. Stiegler, D. C. Anderson, H. M. McClure & R. M. Ruprecht: Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. J Infect Dis 189, 2167-73 (2004)
127. Xu, W., R. Hofmann-Lehmann, H. M. McClure & R. M. Ruprecht: Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV. Vaccine 20, 1956-60 (2002)
128. Hofmann-Lehmann, R., J. Vlasak, R. A. Rasmussen, S. Jiang, P. L. Li, T. W. Baba, D. C. Montefiori, B. J. Bernacky, T. A. Rizvi, R. Schmidt, L. R. Hill, M. E. Keeling, H. Katinger, G. Stiegler, L. A. Cavacini, M. R. Posner & R. M. Ruprecht: Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge. J Med Primatol 31, 109-19 (2002)
129. Hofmann-Lehmann, R., J. Vlasak, R. A. Rasmussen, B. A. Smith, T. W. Baba, V. Liska, F. Ferrantelli, D. C. Montefiori, H. M. McClure, D. C. Anderson, B. J. Bernacky, T. A. Rizvi, R. Schmidt, L. R. Hill, M. E. Keeling, H. Katinger, G. Stiegler, L. A. Cavacini, M. R. Posner, T. C. Chou, J. Andersen & R. M. Ruprecht: Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol 75, 7470-80 (2001)
130. Mascola, J. R., M. G. Lewis, G. Stiegler, D. Harris, T. C. VanCott, D. Hayes, M. K. Louder, C. R. Brown, C. V. Sapan, S. S. Frankel, Y. Lu, M. L. Robb, H. Katinger & D. L. Birx: Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol 73, 4009-18 (1999)
131. Mascola, J. R., M. K. Louder, T. C. VanCott, C. V. Sapan, J. S. Lambert, L. R. Muenz, B. Bunow, D. L. Birx & M. L. Robb: Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12. J Virol 71, 7198-206 (1997)
132. Haigwood, N. L., D. C. Montefiori, W. F. Sutton, J. McClure, A. J. Watson, G. Voss, V. M. Hirsch, B. A. Richardson, N. L. Letvin, S. L. Hu & P. R. Johnson: Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies. J Virol 78, 5983-95 (2004)
133. Doria-Rose, N. A., G. H. Learn, A. G. Rodrigo, D. C. Nickle, F. Li, M. Mahalanabis, M. T. Hensel, S. McLaughlin, P. F. Edmonson, D. Montefiori, S. W.
134. Van Rompay, K. K., M. G. Otsyula, R. P. Tarara, D. R. Canfield, C. J. Berardi, M. B. McChesney & M. L. Marthas: Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection. J Infect Dis 173, 1327-35 (1996)
135. Van Rompay, K. K., J. L. Greenier, K. S. Cole, P. Earl, B. Moss, J. D. Steckbeck, B. Pahar, T. Rourke, R. C. Montelaro, D. R. Canfield, R. P. Tarara, C. Miller, M. B. McChesney & M. L. Marthas: Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. J Virol 77, 179-90 (2003)
136. Marchant, A. & M. Goldman: T cell-mediated immune responses in human newborns: ready to learn? Clin ExpImmunol 141, 10-8 (2005)
137. Zhang, J., N. Silvestri, J. L. Whitton & D. E. Hassett: Neonates mount robust and protective adult-like CD8(+)-T-cell responses to DNA vaccines. J Virol 76, 11911-9 (2002)
138. Barouch, D. H., J. Kunstman, M. J. Kuroda, J. E. Schmitz, S. Santra, F. W. Peyerl, G. R. Krivulka, K. Beaudry, M. A. Lifton, D. A. Gorgone, D. C. Montefiori, M. G. Lewis, S. M. Wolinsky & N. L. Letvin: Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415, 335-9 (2002)
139. Mascola, J. R., M. G. Lewis, T. C. VanCott, G. Stiegler, H. Katinger, M. Seaman, K. Beaudry, D. H. Barouch, B. Korioth-Schmitz, G. Krivulka, A. Sambor, B. Welcher, D. C. Douek, D. C. Montefiori, J. W. Shiver, P. Poignard, D. R. Burton & N. L. Letvin: Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies. J Virol 77, 10348-56 (2003)
140. Rasmussen, R. A., R. Hofmann-Lehmann, P. L. Li, J. Vlasak, J. E. Schmitz, K. A. Reimann, M. J. Kuroda, N. L. Letvin, D. C. Montefiori, H. M. McClure & R. M. Ruprecht: Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques. Aids 16, 829-38 (2002)
141. Lambert, J. S.: HIV vaccines in infants and children. Paediatr Drugs 7, 267-76 (2005)
142. Johnson, D. C., E. J. McFarland, P. Muresan, T. Fenton, J. McNamara, J. S. Read, E. Hawkins, P. L. Bouquin, S. G. Estep, G. D. Tomaras, C. A. Vincent, M. Rathore, A. J. Melvin, S. Gurunathan & J. Lambert: Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women. J Infect Dis 192, 2129-33 (2005)
143. Quay, L. A., P. Musoke, T. Fleming, D. Bagenda, M. Allen, C. Nakabiito, J. Sherman, P. Bakaki, C. Ducar, M. Deseyve, L. Emel, M. Mirochnick, M. G. Fowler, L. Mofenson, P. Miotti, K. Dransfield, D. Bray, F. Mmiro & J. B. Jackson: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354, 795-802 (1999)
144. Eshleman, S. H., L. A. Guay, A. Mwatha, S. P. Cunningham, E. R. Brown, P. Musoke, F. Mmiro & J. B. Jackson: Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012. AIDS Res Hum Retroviruses 20, 595-9 (2004)
145. Eshleman, S. H. & J. B. Jackson: Nevirapine resistance after single dose prophylaxis. AIDS Rev 4, 59-63 (2002)
146. Veazey, R. S., M. S. Springer, P. A. Marx, J. Dufour, P. J. Klasse & J. P. Moore: Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor. Nat Med (2005)
147. Veazey, R. S., P. J. Klasse, S. M. Schader, Q. Hu, T. J. Ketas, M. Lu, P. A. Marx, J. Dufour, R. J. Colonno, R. J. Shattock, M. S. Springer & J. P. Moore: Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438, 99-102 (2005)
148. Taha, T. E., R. J. Biggar, R. L. Broadhead, L. A. Mtimavalye, A. B. Justesen, G. N. Liomba, J. D. Chiphangwi & P. G. Miotti: Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. Bmj 315, 216-9; discussion 220 (1997)
149. Veazey, R. S., M. S. Springer, P. A. Marx, J. Dufour, P. J. Klasse & J. P. Moore: Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor. Nat Med 11, 1293-4 (2005)
150. Allison, R. W. & E. A. Hoover: Feline immunodeficiency virus is concentrated in milk early in lactation. AIDS Res Hum Retroviruses 19, 245-53 (2003)